Earnings reports are critical events for investors as they provide insight into a company's financial health. A worse-than-expected earnings report typically leads to a negative short-term impact on the company's stock price as it may indicate underlying issues or a potential decrease in future profitability. For Co-Diagnostics, the disappointing Q1 results could lead to decreased investor confidence and a short-term decline in stock price.